A promise for neuronal repair: reprogramming astrocytes into neurons in vivo
Bioscience Reports · 2024
DOI: 10.1042/bsr20231717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, 2024. Verfasst von Lijuan Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China. Hauptthemen laut MEDLINE: Astrocytes, Cellular Reprogramming. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The High-Level Medical Expert Training Program of Guangxi "139" Plan Funding, the Guangxi Medical and Health Appropriate Technology Development and Application…, The Clinical Research "Climbing" Program of the First Affiliated Hospital of Guangxi Medical University.
Abstract (Originalsprache)
Massive loss of neurons following brain injury or disease is the primary cause of central nervous system dysfunction. Recently, much research has been conducted on how to compensate for neuronal loss in damaged parts of the nervous system and thus restore functional connectivity among neurons. Direct somatic cell differentiation into neurons using pro-neural transcription factors, small molecules, or microRNAs, individually or in association, is the most promising form of neural cell replacement therapy available. This method provides a potential remedy for cell loss in a variety of neurodegenerative illnesses, and the development of reprogramming technology has made this method feasible. This article provides a comprehensive review of reprogramming, including the selection and methods of reprogramming starting cell populations as well as the signaling methods involved in this process. Additionally, we thoroughly examine how reprogramming astrocytes into neurons can be applied to treat stroke and other neurodegenerative diseases. Finally, we discuss the challenges of neuronal reprogramming and offer insights about the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
- State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting T…
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi, 530021, China.
ORCID-Profile: Lijuan Huang
Förderung
- The National Natural Science Foundation of China
- The High-Level Medical Expert Training Program of Guangxi "139" Plan Funding, the Guangxi Medical and Health Appropriate Technology Development and Application…
- The Clinical Research "Climbing" Program of the First Affiliated Hospital of Guangxi Medical University
- The Clinical Research “Climbing” Program of the First Affiliated Hospital of Guangxi Medical University
Zitieren
APA
Huang, L., Lai, X., Liang, X., Chen, J., Yang, Y., Xu, W., Qin, Q., Qin, R., Huang, X., Xie, M., & Chen, L. (2024). A promise for neuronal repair: reprogramming astrocytes into neurons in vivo. Bioscience Reports. https://doi.org/10.1042/bsr20231717
Vancouver
Huang L, Lai X, Liang X, Chen J, Yang Y, Xu W, et al. A promise for neuronal repair: reprogramming astrocytes into neurons in vivo. Bioscience Reports. 2024. doi:10.1042/bsr20231717
BibTeX
@article{Huang2024,
author = {Huang, Lijuan and Lai, Xinyu and Liang, Xiaojun and Chen, Jiafeng and Yang, Yue and Xu, Wei and Qin, Qingchun and Qin, Rongxing and Huang, Xiaoying and Xie, Minshan and Chen, Li},
title = {A promise for neuronal repair: reprogramming astrocytes into neurons in vivo},
journal = {Bioscience Reports},
year = {2024},
doi = {10.1042/bsr20231717}
}
EUVIMED